Antigen-binding Fragments
Antigen-Binding Fragments is a class of engineered antibody derivatives comprising the minimal structural moiety of an immunoglobulin capable of specifically recognizing and binding to a designated antigenic epitope, distinguished from full-length antibodies by the absence of the crystallizable fragment (Fc) region and reduced molecular size while retaining target specificity.
672
Publications
43K
Citations
3.6K
Authors
870
Institutions
Publications per year
2017–2026
113
Variants
FabFab Fragments
672
1–5 of 672
3.6K
19
h-index
16
h-index
10
h-index
9
h-index
9
h-index
1–5 of 3.6K
870
Vrije Universiteit Brussel
Brussels, Belgium
23 h-index
144 publications
26.3K citations
National Institutes of Health
Bethesda, United States
15 h-index
132 publications
17K citations
Vlaams Instituut voor Biotechnologie
Ghent, Belgium
15 h-index
73 publications
16.1K citations
National Cancer Institute
Bethesda, United States
14 h-index
53 publications
4K citations

Centre National de la Recherche Scientifique
Paris, France
14 h-index
77 publications
3.4K citations
University of Zurich
Zurich, Switzerland
13 h-index
43 publications
7K citations
Scripps Research Institute
San Diego, United States
11 h-index
36 publications
3.2K citations
The University of Tokyo
Tokyo, Japan
11 h-index
40 publications
1.7K citations
1–8 of 870
PNAS · 42 publications · 7.3K citations
36
h-index
JBC · 39 publications · 2.5K citations
26
h-index
Repository · 35 publications · 2.3K citations
24
h-index
PEDS · 23 publications · 1.4K citations
17
h-index
24 publications · 1.2K citations
16
h-index
1–5